Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00818662
Brief Title: A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

First Submitted : January 7, 2009
First Submitted that Met QC Criteria : January 7, 2009
First Posted : January 8, 2009 (Estimate)

Results First Submitted : June 27, 2014
Results First Submitted that Met QC Criteria : October 23, 2014
Results First Posted : October 28, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : October 19, 2017
Last Update Posted : November 24, 2017